Benign Ovarian Cyst
Conditions
Interventions
Experimental Group:Transumbilical Laparoendoscopic Single-Site Ovarian Cystectomy
Control Group:Transvaginal Natural Orifice Transluminal Endoscopic Ovarian Cystectomy
Sponsors
Obstetrics & Gynecology Hospital of Fudan University
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Women of reproductive age, aged 18 to 50 years. 2. Diagnosis of benign ovarian cystic lesions indicated by preoperative imaging (transvaginal ultrasonography, or MRI if necessary), scheduled for ovarian cystectomy. 3. Maximum diameter of the cyst between 4 and 10 cm. 4. No high suspicion of malignancy based on preoperative serum tumor markers (e.g., CA125, CA19-9, AFP, CEA). 5. General condition suitable for laparoscopic surgery, with an American Society of Anesthesiologists (ASA) physical status classification of I or II. 6. Willingness to participate in the study, provide written informed consent, and comply with the follow-up schedule.
Exclusion criteria
Exclusion criteria: 1. Preoperative suspicion or confirmation of ovarian malignancy or borderline tumor, or high suspicion of ovarian endometrioma (chocolate cyst). 2. Vaginal stenosis, acute vaginitis, or obliteration of the pouch of Douglas (cul-de-sac) due to severe pelvic adhesions. 3. History of abdominal surgery (particularly major umbilical or pelvic procedures) likely to cause severe adhesions; or history of incisional hernia. 4. Pregnancy or lactation. 5. Severe medical or surgical comorbidities (e.g., cardiac, pulmonary, hepatic, or renal dysfunction; coagulation disorders) that contraindicate surgery or anesthesia. 6. Cognitive, communication, or psychiatric disorders that prevent effective communication or compliance with questionnaires and follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operative Time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Estimated Blood Loss (EBL);Cyst Rupture Rate;Conversion Rate;Postoperative VAS Score;Postoperative Analgesic Consumption;Time to First Flatus;Time to First Ambulation;Postoperative Length of Stay;Complications;Ovarian Function Indicators (Serum AMH, Ultrasound AFC);Body Image Scale;SF-12/FSFI;SAS/SDS;Cosmetic Satisfaction Score;Total Hospitalization Cost;Instrument Cost;Recurrence Rate; | — |
Countries
China
Contacts
Public ContactXiaojuan Wang
Obstetrics & Gynecology Hospital of Fudan University
Outcome results
None listed